Terms: = Bone cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Prognosis
4 results:
1. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
Duan DK; Zhang GC; Sun BJ; Ma TX; Zhao M
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5039-5052. PubMed ID: 37318478
[TBL] [Abstract] [Full Text] [Related]
2. iTRAQ-based proteomic analysis of the molecular mechanisms and downstream effects of fatty acid synthase in osteosarcoma cells.
Fu D; Liu S; Liu J; Chen W; Long X; Chen X; Zhou Y; Zheng Y; Huang S
J Clin Lab Anal; 2021 Mar; 35(3):e23653. PubMed ID: 33405298
[TBL] [Abstract] [Full Text] [Related]
3. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
[TBL] [Abstract] [Full Text] [Related]
4. N-myc downstream-regulated gene 1/cap43 expression promotes cell differentiation of human osteosarcoma cells.
Matsugaki T; Zenmyo M; Hiraoka K; Fukushima N; Shoda T; Komiya S; Ono M; Kuwano M; Nagata K
Oncol Rep; 2010 Sep; 24(3):721-5. PubMed ID: 20664979
[TBL] [Abstract] [Full Text] [Related]
